Autism spectrum disorder (ASD) includes a heterogeneous group of complex neurodevel opmental disorders characterized by atypical behaviors with two core pathological manifestations: deficits in social interaction/communication and repetitive behaviors, which are associated with disturbed redox homeostasis. Modulation of cellular resilience mechanisms induced by low levels of stressors represents a novel approach for the development of therapeutic strategies, and in this context,
neuroprotective effects of a wide range of
polyphenol compounds have been demonstrated in several in vitro and in vivo studies and thoroughly reviewed by [2, 3]. Mushrooms have been used in
traditional medicine for many years and have been associated with a long list of therapeutic properties, including antitumor, immunomodulatory,
antioxidant,
antiviral, antibacterial, and hepatoprotective effects [4]. Our recent studies have strikingly indicated the presence of
polyphenols in nutritional mushrooms and demonstrated their protective effects in different models of
neurodegenerative disorders in humans and rats [5, 6]. Although their
therapeutic effects are exerted through multiple mechanisms, increasing attention is focusing on their capacity to induce endogenous defense systems by modulating cellular signaling processes, such as nuclear factor erythroid 2 related factor 2 (Nrf2) and
nuclear factor-kappa B (NF-κB) pathways. Here we discuss the protective role of hormesis and its modulation by hormetic nutrients in ASD.